HK$14.73
0.81%
Hong Kong, Oct 08, 04:08 pm HKT. Closed.
ISIN
KYG2524A1031
Symbol
1681

Consun Pharmaceutical Group Stock price

HK$14.73
+1.54 11.68% 1M
-2.35 13.76% 6M
-0.91 5.82% YTD
-2.72 15.59% 1Y
+10.15 221.85% 3Y
+11.18 315.28% 5Y
+10.24 228.03% 10Y
+10.15 221.34% 20Y
Hong Kong, Closing price Thu, Oct 08 2026
-0.12 0.81%
ISIN
KYG2524A1031
Symbol
1681
Industry

Is Consun Pharmaceutical Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$12.3b
Enterprise Value
HK$7.8b
Net debt
positive
Cash
HK$4.7b
Shares outstanding
839.1m
Valuation
P/E
9.2
P/S | estimate
2.9 | 2.6
EV/Sales | estimate
1.8 | 1.7
EV/FCF | ex SBC
- | -
P/B
2.2
Dividends
DPS
HK$0.78
Yield 1Y | 5Y
5.3% | 6.6%
Growth 1Y | 5Y
23.8% | 22.2%
Payout 1Y | 3Y
42.6% | 50.1%
Increased
4 Years
Financials
Revenue | estimate
HK$4.3b | HK$4.6b
EBITDA
-
EBIT
HK$1.6b
Net Income
HK$1.4b
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
11.2% | 15.9%
EBITDA
-
EBIT
23.9%
Net Income
16.5%
Free Cash Flow
-
Margin
Gross
80.1%
EBITDA
-
EBIT
36.6%
Net
32.3%
Free Cash Flow | ex SBC
- | -
Financial Health
Equity Ratio
70.8%
Return on Equity
23.8%
ROCE
25.4%
ROIC
80.8%
Debt/Equity
0.0
More
EPS
HK$1.6
FCF per Share
-
Short interest
-
Employees
3k
Rev per Employee
HK$1.3m

Consun Pharmaceutical Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Consun Pharmaceutical Group forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Consun Pharmaceutical Group forecast:

Buy
88%
Hold
13%

Financial data from Consun Pharmaceutical Group

Jun '26
+/-
%
4,253 4,253
11% 11%
100%
- Direct Costs 846 846
5% 5%
20%
3,407 3,407
16% 16%
80%
- Selling and Administrative Expenses 1,899 1,899
13% 13%
45%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,556 1,556
24% 24%
37%
Net Profit 1,375 1,375
16% 16%
32%

In millions HKD.

Don't miss a Thing! We will send you all news about Consun Pharmaceutical Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. The firm operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The firm's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The firm mainly operates its businesses in the domestic market.

Head office Cayman Islands
CEO Mr. An
Employees 3,115
Website www.chinaconsun.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today